PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385665
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385665
The global revenue from the glucose analysis tubes market reached approximately US$ 480 million in 2024, with a projected CAGR of 5.5%. The market is expected to reach a valuation of approximately US$ 700 million by the end of 2031.
The growth of the global glucose analysis tubes market is attributed to several key factors, including the availability of guidelines on sample collection and storage and the development of novel products. Accurate determination of plasma glucose is essential for diagnosing diabetes and impaired fasting glucose. However, ex-vivo glycolysis, or the drop in glucose levels in blood samples before analysis, can lead to inaccurate results, especially if samples are not stored properly.
To address this issue, inhibitors like sodium fluoride and citrate buffer are used in blood collection tubes to inhibit in vitro glycolysis. International guidelines recommend using such tubes to prevent early glycolysis because ideal sample processing within 30 minutes of blood withdrawal is often not feasible in routine analysis.
The presence of these guidelines, along with ongoing research on glycolysis inhibitors in novel analysis tubes, is expected to drive market growth.
The market for glucose analysis tubes faces challenges related to the need for trained professionals to draw blood, invasiveness of the procedure, and the high cost of care. Minimally invasive or non-invasive glucose analysis devices are becoming more attractive to consumers, potentially limiting the market's growth. Additionally, the cost of glucose analysis strips can be a barrier for patients, leading some to opt for less expensive options.
United States: Lifestyle factors, unhealthy eating habits, and the presence of multiple manufacturers are driving market growth in the U.S. The country's high incidence of blood disorders and lifestyle diseases, coupled with superior healthcare facilities, contribute to the market's expansion in North America.
Russia: Russia has a significant population affected by diabetes, making it a potential market for glucose analysis tubes. The nation ranks sixth globally in terms of diabetes prevalence, and the COVID-19 pandemic has increased the importance of glucose monitoring.
China: China's growing aging population and the presence of local manufacturers contribute to market growth. The incidence of chronic illnesses increases with age, driving the demand for blood sample analysis. Additionally, guidelines for infection prevention in sample collection provide opportunities for market expansion.
Key players in the market are focused on new product development and expansion in emerging regions. Strategies include new product releases, approvals, partnerships, collaborations, and enhanced distribution channels like online sales. The availability of reimbursement for various testing methods further supports market growth.